Kristian F. Humer

Kristian F. Humer serves as the Chief Financial Officer at Foghorn Therapeutics Inc. since April 2024, bringing extensive experience in finance and investment banking. Previously, Kristian held the positions of Chief Financial Officer and Chief Business Officer at Viridian Therapeutics, Inc. from July 2021 to September 2023. Prior to these roles, Kristian had a successful career at Citi, where responsibilities included Managing Director and several leadership roles in Healthcare Investment Banking from January 2010 to July 2021. Additional experience includes Vice President roles at Nomura and Associate positions at Lehman Brothers and UBS. Kristian began a career in investment banking at Merrill Lynch, where roles spanned from Analyst to Associate. Academically, Kristian holds an MBA in Finance from Duke University - The Fuqua School of Business and a Bachelor of Science in Accounting & Economics from the University of Reading.